Modeling Patient Risk for Hospital-Acquired Pressure Injuries During COVID-19: A Retrospective Study


Posted: 2021-10-06 19:00:00
Background: COVID-19 negatively impacts many organ systems including the skin. One of the most significant skin-associated adverse events related to hospitalization are pressure injuries. Purpose: The aim of this study was to determine 8 risk factors that would place hospitalized patients at a higher risk for hospital-acquired pressure injuries (HAPIs) during the COVID-19 pandemic. Methods: A retrospective, descriptive analysis was conducted in an urban academic health science center located in the southeastern United States. Results: There were 247 of 23 093 patients who had pressure injuries and 1053 patients who had a positive COVID-19 diagnosis. Based on the generalized estimating equation model, diagnosis of COVID-19, age, male gender, risk of mortality, severity of illness, and length of stay are statistically significant factors associated with the development of HAPIs. Conclusions: Further study should explore pathology of COVID-19 skin changes and what interventions are effective against HAPIs in the COVID-19 population taking into consideration current treatments.

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
7月 06, 2021 バイオアソシエイツ

感染症の炎症反応からメタボリックシンドロームの人を保護できるかもしれない2種類のペプチドが開発された

バンダービルト大学医療センター(VUMC)の研究者らが開発した細胞貫通ペプチドは、細菌やウイルスの感染によって生じ、しばしば致命的となる敗血症性ショックを動物モデルで予防することができたことが報告された。この研究成果は、2021年6月7日にScientific Reports誌のオンライン版に掲載され、COVID-19を含む微生物感染に対する制御不能な炎症反応による重篤な合併症や死亡のリスクが最も高い患者を保護する方法につなる可能性がある。…

ゲスト 859人 と メンバー 4人 がオンラインです